STAT March 4, 2024
Paul Shay

Lack of health data on LGBTQ+ people has real-world consequences. A participant in a 2020 report from the National LGBT Cancer Network said: “There are no guidelines for cancers that are more prevalent among Trans women. I had to fight like hell to have an anoscopy, and sure enough we found [precancerous lesions]!”

That same year, the National Academies of Sciences, Engineering, and Medicine issued a hallmark report on the health and well-being of LGBTQ+ people. It found that social and structural stigma has contributed to lower rates of engagement with the health care system (such as preventative screenings), higher rates of uninsurance and under-insurance, higher rates of many risk factors including smoking and obesity, higher rates of some cancers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Survey / Study, Trends
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
23andMe: What If …
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article